Ligand validation:8VLK

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8VLK_EDO_D_202	76%	75%	0.085	0.919	0.42	0.55	-	-	0	0	100%	1
8VLK_EDO_A_202	76%	76%	0.093	0.927	0.35	0.59	-	-	0	0	100%	1
8VLK_EDO_B_202	70%	90%	0.108	0.926	0.37	0.24	-	-	0	0	100%	1
8VLK_EDO_A_201	58%	83%	0.116	0.892	0.41	0.37	-	-	0	0	100%	1
8VLK_EDO_B_201	53%	83%	0.137	0.896	0.32	0.45	-	-	0	0	100%	1
8VLK_EDO_D_201	37%	68%	0.162	0.857	0.58	0.66	-	-	1	0	100%	1
8VLJ_EDO_A_202	55%	71%	0.171	0.94	0.68	0.46	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.44	0.35	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.